June 2018 - CanadianCannabisWire

ThursdayJun 28, 2018 12:59 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Floats on Rising Vaporizer Trends

Smoking as a delivery method faces increasing stigma Vaporization set to be a major smoking alternative Sunniva signs contract to supply extraction services to award winning cannabis brand Heightened awareness of the dangers posed by smoking is shaping the fast-developing cannabis marketplace. Smoking, the delivery vehicle of the tobacco industry, is playing a much lesser role. Nicotine may not kill – indeed, it is thought to have some health benefits – but smoking will. So, as markets for adult recreational use of marijuana open up across the U.S., alternative delivery technologies are expected to take center stage. Particularly popular is…

TuesdayJun 26, 2018 12:12 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Pursuing Diverse Applications for DehydraTECH™ Licensing

Lexaria will license in any of the 40 countries where its technology already has a patent or is patent-pending Company sees up to 80 percent of its future revenues coming from licensing DehydraTECH proprietary ingestion delivery technology DehydraTECH™ has applications for processed foods, tobacco industry, pharmaceutical companies, NSAIDs, supplements and beverages Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has a wide variety of licensing applications for its patented DehydraTECH™ delivery technology. It is already licensed to Nuka Enterprises LLC, maker of “1906” brand cannabis chocolates (http://cnw.fm/HD4bm). Chris Bunka, CEO, emphasizes that his company’s technology applies to far more than just the…

TuesdayJun 26, 2018 11:37 am

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Focusing On Innovative Drug Delivery Technologies

Pivot offers unique proprietary drug delivery platform technologies Company has a strong intellectual property (IP) portfolio for the formulation and delivery of cannabinoids Company acquires licensing rights to patented Trivair™ nasal and pulmonary drug delivery system, also signs exclusive manufacturing agreement with Bio V Pharma Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is a biopharmaceutical company based in Vancouver, British Columbia. Pivot engages in the development and commercialization of premium cannabinoid-based nutraceuticals and pharmaceuticals. It does so utilizing unique drug delivery platform technologies. Pivot Pharmaceuticals’ wholly-owned medical cannabis products division is Pivot Green Stream Health Solutions Inc. (“PGS”).…

MondayJun 25, 2018 2:01 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Rolling Forward with Cannabis Production Facility

Facility in Costa Mesa, California, will enable full range of cannabis distribution services Powdered cannabis CBD and THC formulations for beverage alternatives expected to drive multi-billion-dollar market Pivot Pharmaceuticals expects to have licensing to begin manufacturing by July, with equipment installed by August Cannabis-friendly biopharmaceutical firm Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is rolling at a good pace with its recent announcement that its Canada-based operation has also found solid footing in the United States through a lease agreement on a California manufacturing facility that will allow the company to operate wholesale medical marijuana distribution, manufacture, processing…

MondayJun 25, 2018 1:02 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Targets Debilitating Disorders with Novel CBD-based Drug Delivery Platform

Direct health care treatment for chronic health conditions totaled $1.1 trillion in 2016 Total economic impact of $3.7 trillion in health care costs for chronic diseases in U.S. equivalent to nearly 20 percent of the U.S. gross domestic product Medical research into CBD-based therapies to treat epilepsy and other neuropsychiatric disorders holds great promise for affected individuals Development of CBD-based drug delivery platform that’s able to cross blood brain barrier via nasal route Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is developing innovative options for preventive and curative therapies using some of nature’s most compelling…

MondayJun 25, 2018 12:19 pm

Koios Beverage Corp. (CSE: KBEV) is “One to Watch”

Growing worldwide market for nootropics as a safe way for people to boost brain function and earn a competitive edge Non-prescription cognitive enhancers officially became a billion-dollar industry in 2015 Koios, via its GMP-certified and FDA-compliant lab, has developed nootropic products that are made only with high-quality, natural ingredients and are available prescription-free Koios is available in stores and online and is distributed worldwide Koios Beverage Corp. (CSE: KBEV) develops and distributes nature-based products that boost brain function, enhance health, and improve productivity. Its core vision is to help a billion people worldwide live more productively through the development of…

FridayJun 22, 2018 12:54 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Notes Rising Interest in Economic Potential of Industrial Hemp

U.S. legislation to legalize industrial hemp makes significant headway in Congress Non-psychoactive cannabidiol (“CBD”) extracted from industrial hemp expected to become a $1 billion market by 2020 Industrial hemp increasingly seen as an economic boon for farmers seeking alternative agricultural revenue sources Cash Crop Today Investor and Business Resource Summit delivers successful launch during U.S. Hemp History Week Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG) has a vision when it comes to industrial hemp – “One world, one plant.” This seemingly simple statement about an ancient plant with so many beneficial uses is ringing true to investors,…

FridayJun 22, 2018 11:21 am

BLOCKStrain Technology Corp. (TSX.V: DNAX) Positioned to Benefit from Greater Consumer Spending

Cannabis trends leading to greater consumer spending Cannabis pioneer Derek Pedro joins the BLOCKStrain advisory board Company provides an elegant solution, establishing itself as a major player addressing core issues within the global industry The accelerated pace of legalization in the medical and recreational cannabis industries of North America is leading to a projected increase in consumer spending. By 2027, it is estimated that spending on legal cannabis worldwide will reach $57 billion, with North America projected to dominate the market with an expected growth from 2017’s $9.2 billion to $47.3 billion in 2027. According to Tom Adams, editor-in-chief at…

ThursdayJun 21, 2018 12:44 pm

BLOCKStrain Technology Corp. (TSX.V: DNAX) Names 15-Year Legal Cannabis Veteran Derek Pedro to Advisory Board

An industry pioneer, master grower and premier breeder of new cannabis strains, Pedro has a history of participating in Canada’s legalized cannabis industry since 2003 Robert Galarza, DNAX CEO, says Pedro brings expertise to board as company develops its software platform for licensed producers and industry stakeholders Pedro seeks protection for growers’ intellectual property (IP) and ability of government to “track and trace” cannabis shipments, two issues that are the focus of DNAX’s software BLOCKStrain Technology Corp. (TSX.V: DNAX) has named Derek Pedro, an industry veteran of the legalized cannabis industry in Canada, to its advisory board. For joining the advisory…

TuesdayJun 19, 2018 11:48 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Ending the Need to Light-Up

Lexaria is ahead of the game in the expected second flow of investment capital in “plant-to-bloodstream” companies Company’s DehydraTECH™ technology has the potential to revolutionize nicotine use, eliminating the major cause of related deaths by shifting demand away from smoking cigarettes DehydraTECH™ makes it possible to experience most of the positives associated with inhalation while eliminating the negatives, helping to make lighting up a thing of the past Within the cannabis industry, the initial flow of investment capital has been toward ‘seed-to-plant’ companies. As the next stage of investment is expected to be ‘plant-to-bloodstream’, companies such as Lexaria Bioscience Corp.…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977

Month: June 2018